A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects

NCT05646758 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: TQB2934 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.